Abstract
Various guidelines and risk indices have optimized cardiac risk stratification, and the emphasis has shifted to reducing perioperative risk. This review is an update on invasive (CABG/PCI) and noninvasive (medical therapy with beta-blockers, alpha-agonists, and statins) strategies to reduce cardiac risk for noncardiac surgery and the controversies surrounding their use.
| Original language | English |
|---|---|
| Pages (from-to) | 174-180 |
| Number of pages | 7 |
| Journal | Journal of Hospital Medicine |
| Volume | 2 |
| Issue number | 3 |
| DOIs | |
| State | Published - May 2007 |
| Externally published | Yes |
Fingerprint
Keywords
- Beta-adrenergic blockers
- Coronary artery bypass
- Percutaneous coronary intervention
- Perioperative
- Preoperative care
- Risk assessment
- Statin
ASJC Scopus subject areas
- Health Policy
- Assessment and Diagnosis
- Care Planning
- Fundamentals and skills
- Leadership and Management
Cite this
Preoperative cardiac risk stratification 2007 : Evolving evidence, evolving strategies. / Lawrence Cohn, Steven; Auerbach, Andrew D.
In: Journal of Hospital Medicine, Vol. 2, No. 3, 05.2007, p. 174-180.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Preoperative cardiac risk stratification 2007
T2 - Evolving evidence, evolving strategies
AU - Lawrence Cohn, Steven
AU - Auerbach, Andrew D.
PY - 2007/5
Y1 - 2007/5
N2 - Various guidelines and risk indices have optimized cardiac risk stratification, and the emphasis has shifted to reducing perioperative risk. This review is an update on invasive (CABG/PCI) and noninvasive (medical therapy with beta-blockers, alpha-agonists, and statins) strategies to reduce cardiac risk for noncardiac surgery and the controversies surrounding their use.
AB - Various guidelines and risk indices have optimized cardiac risk stratification, and the emphasis has shifted to reducing perioperative risk. This review is an update on invasive (CABG/PCI) and noninvasive (medical therapy with beta-blockers, alpha-agonists, and statins) strategies to reduce cardiac risk for noncardiac surgery and the controversies surrounding their use.
KW - Beta-adrenergic blockers
KW - Coronary artery bypass
KW - Percutaneous coronary intervention
KW - Perioperative
KW - Preoperative care
KW - Risk assessment
KW - Statin
UR - http://www.scopus.com/inward/record.url?scp=34447126249&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34447126249&partnerID=8YFLogxK
U2 - 10.1002/jhm.158
DO - 10.1002/jhm.158
M3 - Article
C2 - 17549772
AN - SCOPUS:34447126249
VL - 2
SP - 174
EP - 180
JO - Journal of hospital medicine (Online)
JF - Journal of hospital medicine (Online)
SN - 1553-5606
IS - 3
ER -